OBSOLETE: Adenoid cystic carcinoma of the corpus uteri

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:213741
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Adenoid cystic carcinoma of the corpus uteri (body of the uterus) is an extremely rare type of cancer that develops in the main body of the womb. This condition is classified as 'obsolete' in the Orphanet database, meaning it is no longer tracked as a separate disease entry, likely because it has been reclassified or merged into a broader category of rare uterine cancers. Adenoid cystic carcinoma (ACC) is a type of cancer more commonly found in the salivary glands, but it can very rarely occur in other parts of the body, including the uterus. When it does appear in the uterus, it tends to behave differently from the more common types of uterine cancer such as endometrial adenocarcinoma. Symptoms may include abnormal vaginal bleeding (especially after menopause), pelvic pain, unusual vaginal discharge, and a feeling of fullness or pressure in the pelvis. Because this cancer is so rare, there is no standardized treatment protocol specific to it. Treatment typically follows general principles used for other rare uterine cancers and may include surgery (such as hysterectomy), radiation therapy, and sometimes chemotherapy. The rarity of this condition means that most knowledge comes from individual case reports rather than large clinical studies, making it important for patients to seek care at specialized cancer centers with experience in rare gynecologic tumors.

Also known as:

Key symptoms:

Abnormal vaginal bleedingBleeding after menopausePelvic pain or pressureUnusual vaginal dischargeFeeling of fullness in the lower bellyPain during intercourseUnexplained weight lossFatigueDifficulty urinating or changes in bladder habitsLower back pain

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Adenoid cystic carcinoma of the corpus uteri community →

No specialists are currently listed for OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Adenoid cystic carcinoma of the corpus uteriForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Adenoid cystic carcinoma of the corpus uteri.

Start the conversation →

Latest news about OBSOLETE: Adenoid cystic carcinoma of the corpus uteri

1 articles
Clinical trialCLINICALTRIALSMar 26, 2026
New Clinical Trial: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)
Researchers are testing two cancer-fighting drugs called nivolumab and ipilimumab together to treat patients with rare types of cancer. These drugs help the bod
See all news about OBSOLETE: Adenoid cystic carcinoma of the corpus uteri

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What stage is my cancer, and has it spread beyond the uterus?,What treatment plan do you recommend, and what are the goals of each treatment?,How experienced is your team with this very rare type of uterine cancer?,Are there any clinical trials available for adenoid cystic carcinoma?,What side effects should I expect from the recommended treatments?,How often will I need follow-up visits, and what will monitoring involve?,Should molecular or genetic testing be done on my tumor to look for targetable mutations?

Common questions about OBSOLETE: Adenoid cystic carcinoma of the corpus uteri

What is OBSOLETE: Adenoid cystic carcinoma of the corpus uteri?

Adenoid cystic carcinoma of the corpus uteri (body of the uterus) is an extremely rare type of cancer that develops in the main body of the womb. This condition is classified as 'obsolete' in the Orphanet database, meaning it is no longer tracked as a separate disease entry, likely because it has been reclassified or merged into a broader category of rare uterine cancers. Adenoid cystic carcinoma (ACC) is a type of cancer more commonly found in the salivary glands, but it can very rarely occur in other parts of the body, including the uterus. When it does appear in the uterus, it tends to beha

How is OBSOLETE: Adenoid cystic carcinoma of the corpus uteri inherited?

OBSOLETE: Adenoid cystic carcinoma of the corpus uteri follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Adenoid cystic carcinoma of the corpus uteri typically begin?

Typical onset of OBSOLETE: Adenoid cystic carcinoma of the corpus uteri is adult. Age of onset can vary across affected individuals.